Life expectancy of at least 3 months

ECOG stauts less than or equal to 2

histologically confirmed diagnosis of non melanoma skin cancer

standard therapy does not work or refused

must have injectable lesion greater than 3 mm in longest diameter.

must meet following bone marrow details: 
Hemoglobin (Hb) > LLN 10 g/dL
White Blood Cell Count (WBC) > LLN 3,000 cells/mcL
Platelet count (PLT) > LLN - 75,000 /mcL
Blood Coagulation Parameters

PT, INR < 1.5 x institutional ULN unless patient is therapeutically anticoagulated.Patients who are receiving anticoagulants may participate in the trial if their anticoagulation can be stopped safely for several days at the time of biopsy.

Serum Creatinine (SCr) < 1 - 1.5 x baseline; < 1 1.5 x ULN

Blood bilirubin < 1 - 1.5 x ULN if baseline was normal; < 1 1.5 x baseline if baseline was abnormal
Serum Alanine Aminotransferase (ALT) < 1 - 3 x ULN if baseline was normal; 1.5 3 x baseline if baseline was abnormal
Serum Aspartate Aminotransferase (AST) < 1 - 3 x ULN if baseline was normal; 1.5 3 x baseline if baseline was abnormal
Alkaline Phosphatase (ALP) < 1 - 2.5 x ULN if baseline was normal; 2 2.5 x baseline if baseline was abnormal
Gamma Glutylamyltransferase (GGT) < 1 - 2.5 x ULN, if baseline was normal; 2 2.5 x baseline if baseline was abnormal

must consent to use contraception prior to study untill 6 months after study

can not be pregnant or become pregnant during study

can not breastfeed during study

must sign legal consent form

can not be in any other trial within 28 days before

can not have have received oncological therapy 2 weeks before planned injection

can not have central nervous system metastasis (unless its stable for more than 4 weeks)

can not have Concurrent steroid therapy (> 10 mg of daily prednisone equivalent) or other immunosuppressive therapies such as those needed for solid organ transplants and rheumatoid arthritis. Topical or inhaled steroids are allowable.

can not have a histroy of organ allograft transplantation

can not have history of hemolytic anemia

can not have a history of signifcant tumor bleeding or coagulation/bleeding disorders which could deem an injection dangerous.

can not have autoimmune disorder unless its is being treated. 

can not have major surgery within 14 days of study

must have recovered from any side effects in any prior sureries prior to start diathesis

must not have Leptomeningeal involvement regardless of treatment status

must not have Active, clinically serious uncontrolled medical conditions such as HIV, HBV, HCV, and EBV infection or an Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with protocol requirements

must be willing and able to follow protocol requirements

26 total
